|
|
|
You can get e-magazine links on WhatsApp. Click here
|
|
|
|
|
|
India’s first Ayurvedic cannabis solution for menstrual cramps
|
|
Monday, 04 January, 2021, 08 : 00 AM [IST]
|
|
Our Bureau, New Delhi
|
As per a study published in the British Medical Journal, Menstrual symptoms including pain, heavy bleeding and low mood may be linked to nearly nine days of lost productivity per woman every year. A focus group study indicates that 84.1 per cent women reported the occurrence of Menstrual cramps or primary dysmenorrhea during their menstrual cycles.
Periods are usually associated with mild, tolerable lower abdomen or back discomfort but the pain (dysmenorrhoea) can be severe enough to interfere with day-to-day activities. The existing solutions in modern healthcare and allopathic medicine system are known to have harmful side effects in long term. In its endeavour to offer a more sustainable, herbal and ayurvedic solution for medical cramps, India’s first research to retail venture in the Ayurvedic Cannabis (Bhang) sector, HempStreet announced the launch of medicinal cannabis based Trailokya Vijaya Vati.
Trailokya Vijaya Vati is an Ayurvedic solution to this widely prevalent issue. It is a time tested classical ayurveda medicine, having cannabis as one of its key ingredients and has been known to be extremely effective in soft tissue muscle pains like menstrual cramps and spasms. Based on the initial feedback study with over 2,000 Ayurveda practitioners across India, the medicine has proven to be extremely effective and the same is true from the massive adoption that it has witnessed in a brief period of time.
Shrey Jain, co-founder, HempStreet, said “Menstruation as a topic is highly stigmatized in our country. Period pain is often ignored by making a significant part of women lifestyle and working hours stressful and painful. But the fact is that women have even described the cramping pain as 'almost as bad as having a heart attack.' On an average, a woman goes through around 450 menstrual cycles throughout her lifetime. Irony is that the available solutions in modern medical science possess threat of serious harmful effects in case of long term consumption. Trailokya Vijaya Vati aims at providing a reliable, safe and ayurvedic solution to the women of 21st century.”
“Hempstreet is working in conjunction with top notch scientists to conduct research and development around safe medication by leveraging the immense potential and natural power of Cannabis. Today HempStreet boasts of 15 approved products and a world-class research partnership with Council of Scientific and Industrial Research (CSIR). We have successfully reached out to extensive doctor network of 43000 doctors and 230 clinics to provide medical cannabis medicine, primarily to alleviate the huge menstrual pain relief crisis in India. The company strive to bring an effective and responsible usage of Cannabis, especially on the pain relief front, to its potential addressable patient base of over 35 million individuals”, he added.
The Cannabis Sativa plant, which encompasses hemp, cannabis, and marijuana, contains more than 100 different chemicals called cannabinoids. These are used to treat many diseases and conditions, including chronic pain, insomnia, anxiety, menstrual cramps, muscle spasms, mental health, epilepsy, and multiple sclerosis, sexual disorders, and more. The legal Cannabis industry is currently one of the fastest growing industries in the world. According to a report by Grand View Research Inc., the global legal marijuana market is predicted to reach USD $146.4 billion by the end of 2025.
Cannabis is recognised as one of the five key medicinal plants in Vedas. Cannabis history in India can be traced back to 1000 BC. As per classical ayurvedic texts nearly 191 formulations and more than 15 dosage forms have Cannabis as a key ingredient. Government is working very hard as Medicinal Marijuana or Cannabis will be legalized soon. Scientists are aggressively working to find out the active components of Cannabis. CSIR Indian Institute of Integrative Medicine is the first institute to get government approval for Cannabis.
The company has recently secured $1,000,000 ( approximately Rs 8 Crore) in Pre-Series A Funding round. This Pre-Series A funding was led by Pharmacon Holdings, a US based Pharma Tech company and Romain Berberis, a long time Private Investor in the Cannabis space in the US and Canada. The company has plans to utilise the funds for category disruption, tech development, research and brand building.
|
|
|
|
|
|
|
|
|
|